Free Republic
Browse · Search
General/Chat
Topics · Post Article

To: Robert DeLong

RE: Sigh, so it is not a prophylactic in those who have immunity issues.

I’m not sure what you mean by “in those who have immunity issues”.

Do we differentiate between people who have and have NOT immunity issues?

OK, let’s move the discussion further along...let’s agree that for those with immunity issues (e.g., those who have serious pre-existing conditions ), it does not act as a prophylactic.

What about those who are HEALTHY? Will it act as a prophylactic?


72 posted on 04/19/2020 7:59:06 AM PDT by SeekAndFind (look at Michigan, it will)
[ Post Reply | Private Reply | To 71 | View Replies ]


To: SeekAndFind
It's a flawed test when you drill down to the details. While they identify those with immune issues, they don't really give details regarding those who are not lupus and rheumatoid arthritis patients. Were they obese, did they have diabetes? Could they have other underlying issues that has affected their immune systems.

This guy surely isn't a biased actor in this, right?????

Jinoos Yazdany, chief of the division of rheumatology at Zuckerberg San Francisco General Hospital, told The Wall Street Journal that the antimalarial doesn’t fully protect people from contracting the new virus and is “not a magic bullet because people that are on it are contracting the infection.”

I'm disappointed that Epoch Times didn't pick up on this, and ask him questions that I am asking.

No one has made the claim that it is a magic bullet. That phrase is being used as a dog whistle in case you haven't learned this yet. Instead they have said that it helps patients recover, and that it is at least something that can be used to fight back against the virus and save lives.

83 posted on 04/19/2020 8:16:58 AM PDT by Robert DeLong
[ Post Reply | Private Reply | To 72 | View Replies ]

Free Republic
Browse · Search
General/Chat
Topics · Post Article


FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson